The case involving Sagar Ramakant Joshi and E-Biotorium Network Pvt Ltd has drawn attention due to allegations of medical misrepresentation, workplace misconduct, and regulatory violations. Authorities, including the National Commission for Indian System of Medicine, are examining claims related to unauthorised use of medical titles and branding. Additional scrutiny covers product claims, compliance with safety laws, and ongoing criminal cases. While allegations remain subject to investigation, the matter raises broader concerns about consumer protection, workplace governance, and regulatory enforcement in India.

Sagar Ramakant Joshi case: E-Biotorium CMD faces allegations of medical misrepresentation, sexual misconduct, and regulatory violations

Serious allegations against Sagar Ramakant Joshi and E-Biotorium raise concerns over medical claims, workplace conduct, and compliance with Indian laws, drawing attention from multiple regulatory authorities.

Rape accused Sagar Ramakant Joshi case has come under scrutiny after allegations of medical misrepresentation, sexual misconduct, and statutory violations linked to E-Biotorium surfaced in Mumbai and Thane.

The company, known for marketing “Bio-Magnetic” mattresses, is facing multiple complaints, while its Chairman and Managing Director, Sagar Ramakant Joshi, is reportedly under investigation by authorities.

Medical claims and alleged misuse of the ‘Dr.’ title raise questions

According to available documents and regulatory references, Sagar Ramakant Joshi has allegedly used the prefix “Dr.” despite no publicly verifiable record of recognised medical qualifications.

The National Commission for Indian System of Medicine (NCISM), under reference MCIM/2307264/2023, has reportedly initiated an inquiry into alleged unauthorised use of the Ministry of AYUSH logo.

Officials have indicated that continued use of the AYUSH branding without approval may constitute a prima facie case of misrepresentation under applicable Indian laws and regulatory frameworks.

To view the related document related to the AYUSH logo- Click here

E-Biotorium operations and consumer claims under scanner

E-Biotorium markets products such as bio-magnetic mattresses, claiming benefits for conditions including blood pressure, thyroid disorders, and migraine, raising questions over scientific validation and regulatory approval.

Authorities are examining whether these health-related claims comply with standards laid down by the Central Drugs Standard Control Organisation (CDSCO) and other statutory bodies governing medical products.

Allegations have also surfaced regarding financial irregularities, including delayed distributor payments and possible GST compliance issues, though these claims remain subject to official verification.

Sexual misconduct allegations and workplace compliance concerns

Sagar Ramakant Joshi is reported to be an accused in two separate rape cases, with investigations ongoing as per legal procedures. The allegations have intensified scrutiny of workplace practices within E-Biotorium.

Former employees have reportedly raised concerns regarding workplace conduct, alleging inappropriate behaviour and a lack of institutional safeguards for women employees within the organisation.

The company is also alleged to have failed to comply with the Prevention of Sexual Harassment (POSH) Act, including the absence of a functional Internal Complaints Committee (ICC), a mandatory legal requirement.

Authorities, including the Collector of Thane and departments linked to Women and Child Welfare in Delhi, are reportedly examining compliance aspects related to employee protection norms.

Also Read: Thane Share Market Scam: ₹500 Crore Fraud Claims Surface.

Legal concerns over privacy and the handling of sensitive information

Legal experts have flagged concerns regarding the alleged circulation of unredacted FIR copies containing survivor details, which could potentially violate privacy protections under Indian law.

Such actions, if established, may conflict with Supreme Court guidelines, including the March 2026 ruling (2026 INSC 290), which strongly discourages disclosure of survivor identities in sensitive cases.

Experts indicate that such violations could have implications for ongoing legal proceedings, including bail considerations, subject to judicial review and due process.

Regulatory scrutiny and broader implications for E-Biotorium

E-Biotorium’s operations are reportedly under the scanner of multiple regulatory bodies, including NCISM, CDSCO, and consumer protection authorities such as the Central Consumer Protection Authority (CCPA).

The case highlights broader concerns regarding the enforcement of medical advertising norms, workplace safety laws, and compliance with consumer protection regulations in emerging health product markets.

Industry observers note that increased scrutiny may lead to stricter enforcement actions if violations are established through formal investigation and regulatory findings.

What lies ahead in the Sagar Ramakant Joshi case

The outcome of investigations into Sagar Ramakant Joshi and E-Biotorium will depend on findings by regulatory authorities and decisions of competent courts handling related cases.

Authorities are expected to examine all allegations through due legal procedures, ensuring adherence to statutory frameworks and safeguarding the rights of all parties involved in the matter.

As the situation develops, the case may serve as a benchmark for accountability in health-related marketing and corporate governance, according to inputs reviewed by Sprouts News.

Editorial Note:

This article is based on publicly available FIR records, court case references, and reports published by multiple media organisations. The information is presented in the context of ongoing investigations and public interest reporting. Sprouts News does not make any judicial determination regarding the individuals mentioned and does not intend to defame any person or organisation. Any individual seeking clarification or wishing to provide an official response may contact the editorial team with verifiable documentation. The information is presented for journalistic and informational purposes.